Published in Infect Immun on April 01, 1999
Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev (2011) 5.15
Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice. Vaccine (2010) 1.54
Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations. Infect Immun (2004) 1.14
Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine. Infect Immun (2002) 1.13
Hemolytic C-type lectin CEL-III from sea cucumber expressed in transgenic mosquitoes impairs malaria parasite development. PLoS Pathog (2007) 1.13
Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum. Infect Immun (2005) 1.05
A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity. PLoS One (2011) 1.05
Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation. Vaccine (2007) 1.03
Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding. Infect Immun (2014) 0.96
Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen. Infect Immun (2004) 0.92
Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons. Vaccine (2013) 0.87
Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles. Vaccine (2015) 0.85
Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America. Mem Inst Oswaldo Cruz (2011) 0.80
Evaluation of the Impact of Codon Optimization and N-Linked Glycosylation on Functional Immunogenicity of Pfs25 DNA Vaccines Delivered by In Vivo Electroporation in Preclinical Studies in Mice. Clin Vaccine Immunol (2015) 0.78
Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45. Infect Immun (2006) 0.77
Plant expression and characterization of the transmission-blocking vaccine candidate PfGAP50. BMC Biotechnol (2015) 0.77
Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes. Infect Immun (2015) 0.76
Strategies & recent development of transmission-blocking vaccines against Plasmodium falciparum. Indian J Med Res (2016) 0.75
Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation. Vaccine (2016) 0.75
Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii. Parasit Vectors (2016) 0.75
Impact of the Charge Ratio on the In Vivo Immunogenicity of Lipoplexes. Pharm Res (2017) 0.75
Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 10.14
DNA vaccines. Annu Rev Immunol (1997) 5.05
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med (1998) 4.13
Complete in vitro maturation of Plasmodium falciparum gametocytes. Nature (1981) 3.88
Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science (1998) 3.46
A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature (1988) 3.31
Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods (1986) 3.07
Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J Exp Med (1985) 2.59
Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci U S A (1994) 2.58
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci U S A (1997) 2.35
The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J Immunol (1987) 2.18
Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J Exp Med (1996) 2.15
Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J Exp Med (1991) 2.15
Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc Natl Acad Sci U S A (1998) 1.93
Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. Infect Immun (1994) 1.87
Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. J Immunol (1991) 1.78
A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines. Infect Immun (1997) 1.71
Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus. Science (1991) 1.59
Plasmodium gallinaceum: exflagellation stimulated by a mosquito factor. Exp Parasitol (1979) 1.46
Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology (1995) 1.46
Immunity to sexual stages of malaria parasites. Prog Allergy (1988) 1.31
Transmission-blocking immunity against malaria and other vector-borne diseases. Curr Opin Immunol (1993) 1.31
Sexual differentiation in malaria parasites. Annu Rev Microbiol (1990) 1.26
Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol Biochem Parasitol (1993) 1.20
Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine (1994) 1.18
DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine (1996) 1.15
Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures. Mol Biochem Parasitol (1986) 1.14
Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent. Infect Immun (1995) 1.08
Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity. Proc Natl Acad Sci U S A (1991) 1.02
Towards a DNA vaccine against tuberculosis. Vaccine (1994) 0.99
Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens. J Exp Med (1992) 0.93
Expression of early gametocyte-stage antigens Pfg27 and Pfs16 in synchronized gametocytes and non-gametocyte producing clones of Plasmodium falciparum. Mol Biochem Parasitol (1994) 0.93
Malaria transmission-blocking immunity. Identification of epitopes and evaluation of immunogenicity. Adv Exp Med Biol (1995) 0.86
Mapping of two overlapping linear epitopes in Pfg27 recognized by Plasmodium falciparum transmission-blocking monoclonal antibodies. Vaccine (1995) 0.83
Nucleic acid-based vaccines as an approach to immunization against human immunodeficiency virus type-1. Curr Top Microbiol Immunol (1998) 0.80
Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum. Pept Res (1997) 0.79
The genome of simian virus 40. Science (1978) 24.46
Simian virus 40 tandem repeated sequences as an element of the early promoter. Proc Natl Acad Sci U S A (1981) 13.67
Mechanism of activation of a human oncogene. Nature (1982) 12.09
Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions. Proc Natl Acad Sci U S A (1980) 7.77
The genome of human papovavirus BKV. Cell (1979) 6.36
Kuppuswamy's socioeconomic status scale-updating for 2007. Indian J Pediatr (2007) 6.26
ras-Related gene sequences identified and isolated from Saccharomyces cerevisiae. Nature (1984) 5.32
Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis (2001) 5.27
BKV splice sequences based on analysis of preferred donor and acceptor sites. Nucleic Acids Res (1979) 4.86
Novel mechanism for RNA maturation: the leader sequences of simian virus 40 mRNA are not transcribed adjacent to the coding sequences. Proc Natl Acad Sci U S A (1977) 4.64
Mapping the spliced and unspliced late lytic SV40 RNAs. Cell (1978) 4.25
Splicing as a requirement for biogenesis of functional 16S mRNA of simian virus 40. Proc Natl Acad Sci U S A (1979) 3.89
Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus. Science (1982) 3.55
Comparison of the nucleotide sequence of the messenger RNA for the major structural protein of SV40 with the DNA sequence encoding the amino acids of the protein. Nucleic Acids Res (1977) 3.00
Identification of a precursor in the biosynthesis of the p21 transforming protein of harvey murine sarcoma virus. J Virol (1982) 2.89
Processing and expression of early SV40 mRNA: a role for RNA conformation in splicing. Cell (1979) 2.80
Tunnelling epidural catheters: a worthwhile exercise? Anaesthesia (2000) 2.76
A rapid enzymatic DNA sequencing technique: determination of sequence alterations in early simian virus 40 temperature sensitive and deletion mutants. Nucleic Acids Res (1980) 2.65
Characterization of the phosphorylation sites and the surrounding amino acid sequences of the p21 transforming proteins coded for by the Harvey and Kirsten strains of murine sarcoma viruses. J Biol Chem (1982) 2.59
Quorum-sensing cross talk: isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosa and other gram-negative bacteria. Mol Microbiol (1999) 2.59
Transferable EST-SSR markers for the study of polymorphism and genetic diversity in bread wheat. Mol Genet Genomics (2003) 2.55
Structure of a large segment of the genome of simian virus 40 that does not encode known proteins. Proc Natl Acad Sci U S A (1977) 2.50
The nucleotide sequence preceding an RNA polymerase initiation site on SV40 DNA. Part 2. The sequence of the early strand transcript. Nucleic Acids Res (1974) 2.40
Evidence that halogenated furanones from Delisea pulchra inhibit acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein. Microbiology (1999) 2.37
Nucleotide sequences of RNA transcribed in infected cells and by Escherichia coli RNA polymerase from a segment of simian virus 40 DNA. Proc Natl Acad Sci U S A (1974) 2.34
Carbon nanotube flow sensors. Science (2003) 2.23
T1-weighted dynamic contrast-enhanced MR evaluation of different stages of neurocysticercosis and its relationship with serum MMP-9 expression. AJNR Am J Neuroradiol (2012) 2.23
A novel and sensitive method for the quantification of N-3-oxoacyl homoserine lactones using gas chromatography-mass spectrometry: application to a model bacterial biofilm. Environ Microbiol (2000) 2.22
The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J Immunol (1987) 2.18
Taxol-induced polymerization of purified tubulin. Mechanism of action. J Biol Chem (1981) 2.13
Nucleotide sequence of two rasH related-genes isolated from the yeast Saccharomyces cerevisiae. Nucleic Acids Res (1984) 2.10
The burden of polyparasitism among primary schoolchildren in rural and farming areas in Zimbabwe. Trans R Soc Trop Med Hyg (2008) 2.05
A mutation in the Schizosaccharomyces pombe rae1 gene causes defects in poly(A)+ RNA export and in the cytoskeleton. J Biol Chem (1995) 2.05
Aspirin concurrently administered with ranitidine does not delay healing of duodenal ulcer. Aust N Z J Med (1990) 2.04
Clinical presentation of adult coeliac disease. Ir Med J (2011) 2.04
Nonviral oligonucleotides at the 5' terminus of cytoplasmic influenza viral mRNA deduced from cloned complete genomic sequences. Cell (1980) 1.91
Nucleotide sequence about the 3' terminus of SV40 DNA transcripts and the region where DNA synthesis is initiated. Cold Spring Harb Symp Quant Biol (1975) 1.89
The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology (1990) 1.87
Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology (2005) 1.75
A large simple randomized trial of rocuronium versus succinylcholine in rapid-sequence induction of anaesthesia along with propofol. Acta Anaesthesiol Scand (1999) 1.69
Nucleotide sequence of the BK virus DNA segment encoding small t antigen. Proc Natl Acad Sci U S A (1979) 1.67
Oral and dental aspects of chronic renal failure. J Dent Res (2005) 1.64
Preferential action of a brain detyrosinolating carboxypeptidase on polymerized tubulin. J Biol Chem (1981) 1.62
Nucleotide sequence of the DNA replication origin for human papovavirus BKV: sequence and structural homology with SV40. Cell (1978) 1.61
cDNA cloning of porcine transforming growth factor-beta 1 mRNAs. Evidence for alternate splicing and polyadenylation. J Biol Chem (1988) 1.58
Echocardiography in systemic lupus erythematosus. Lupus (1998) 1.56
Concurrent dengue virus and Japanese encephalitis virus infection of the brain: is it co-infection or co-detection? Infection (2012) 1.52
Microfilariae in association with neoplastic lesions: report of five cases. Cytopathology (2001) 1.50
The 'red ear syndrome' revisited: two cases and a review of literature. Cephalalgia (2004) 1.49
The nucleotide sequence preceding an RNA polymerase initiation site on SV40 DNA. Part 1. The sequence of the late strand transcript. Nucleic Acids Res (1974) 1.48
Financing long-term care: a practical mix of public and private. J Health Polit Policy Law (1992) 1.47
Parkinsonism and tardive antecollis in frontotemporal dementia--increased sensitivity to newer antipsychotics? Eur J Neurol (2008) 1.47
The human RAE1 gene is a functional homologue of Schizosaccharomyces pombe rae1 gene involved in nuclear export of Poly(A)+ RNA. Gene (1997) 1.45
Transversus abdominis plane block using the loss of resistance to air technique. Minerva Anestesiol (2012) 1.43
Hydrocolonic sonography in the evaluation of colonic lesions. Abdom Imaging (1999) 1.42
Carbon source regulation of RAS1 expression in Saccharomyces cerevisiae and the phenotypes of ras2- cells. Proc Natl Acad Sci U S A (1986) 1.42
Effect of visual impairment upon oral health care: a review. Br Dent J (2008) 1.42
Tonometer disinfection practice in the United Kingdom: a national survey. Eye (Lond) (2007) 1.41
The challenge of valve surgery in a developing population. J Heart Valve Dis (1993) 1.40
Interaction of tubulin with phospholipid vesicles. I. Association with vesicles at the phase transition. J Biol Chem (1981) 1.40
Reference values for peak expiratory flow in Indian adult population using a European Union scale peak flow meter. J Postgrad Med (2014) 1.40
Mandibular nerve block for peri-operative pain relief using a peripheral nerve stimulator. Anaesthesia (2012) 1.40
Modulation of some parameters of assembly of microtubules in vitro by tyrosinolation of tubulin. Eur J Biochem (1982) 1.39
An indigenous leucocyte esterase test along with Pandy's test for the diagnosis of bacterial meningitis. Indian Pediatr (2001) 1.39
Primary care guidelines in rheumatology. Rheumatology (Oxford) (2006) 1.39
Balloon dilatation of inferior vena cava stenosis in Budd-Chiari syndrome. J Assoc Physicians India (1996) 1.39
Accelerated degeneration of aortic homograft in an infant. J Thorac Cardiovasc Surg (1994) 1.39
Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol (1988) 1.38
The aetiology of perforating ocular injuries in children. Br J Ophthalmol (2002) 1.37
A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies. Infect Immun (1984) 1.36
p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter. J Biol Chem (1999) 1.34
Elective surgery for corrosive-induced gastric injury. World J Surg (1996) 1.33
Anopheles gambiae salivary gland proteins as putative targets for blocking transmission of malaria parasites. Proc Natl Acad Sci U S A (2000) 1.32
Immunity to sexual stages of malaria parasites. Prog Allergy (1988) 1.31
Mycotic keratitis in children: epidemiologic and microbiologic evaluation. Cornea (1997) 1.29
Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Trans R Soc Trop Med Hyg (2008) 1.29
Biosynthesis of the target antigens of antibodies blocking transmission of Plasmodium falciparum. Mol Biochem Parasitol (1984) 1.24
Consequences of polyparasitism on anaemia among primary school children in Zimbabwe. Acta Trop (2010) 1.23
Identification of the nature and source of atmospheric aerosols near the Taj Mahal (India). Environ Monit Assess (1995) 1.22
Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases. Ann Trop Med Parasitol (1998) 1.22
Leishmania donovani in blood smears of asymptomatic persons. Acta Trop (2000) 1.22
Disruption of the Pfg27 locus by homologous recombination leads to loss of the sexual phenotype in P. falciparum. Mol Cell (1999) 1.21
Methylation of nuclear simian virus 40 RNAs. J Virol (1979) 1.21
Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc Natl Acad Sci U S A (1999) 1.19
QTL analysis for grain protein content using SSR markers and validation studies using NILs in bread wheat. Theor Appl Genet (2002) 1.19
High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine (2008) 1.17
Preparation of RNA transcripts of discrete segments of DNA. Methods Enzymol (1974) 1.17
Fragmented esophageal smooth muscle contraction segments on high resolution manometry: a marker of esophageal hypomotility. Neurogastroenterol Motil (2012) 1.17
Nucleotides sequence of the genes for the simian virus 40 proteins VP2 and VP3. J Biol Chem (1978) 1.16
Role of polyamines and ethylene as modulators of plant senescence. J Biosci (2000) 1.16
Small bowel obstruction in pregnancy. Am J Gastroenterol (1995) 1.16
Are rheumatologists' treatment decisions influenced by patients' age? Rheumatology (Oxford) (2006) 1.15
Nucleotide sequence of the two rat cellular rasH genes. Mol Cell Biol (1986) 1.15
Mediastinal hibernoma. Eur J Cardiothorac Surg (1999) 1.14
Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites. J Immunol (1995) 1.12